SCHEMBL3149641

SCHEMBL3149641

Cc1ccc(C)c(C#C[Cu])c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.46
FFAR1 O14842 1/20 0.41
TDP1 Q9NUW8 4/20 0.39
ALDH1A1 P00352 2/20 0.39
RET P07949 1/20 0.35
CYP1A2 P05177 4/20 0.35
CYP2A6 P11509 2/20 0.35
TP53 P04637 2/20 0.34
TAAR1 Q96RJ0 1/20 0.33
HSD17B10 Q99714 2/20 0.32
GAA P10253 2/20 0.32
RAPGEF4 Q8WZA2 1/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
CYP3A4 P08684 1/20 0.31
THRB P10828 1/20 0.31
ALOX15 P16050 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
TRPA1 O75762 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL80391 0.72 FFAR1 (0.45) GRM5FFAR1TDP1ALDH1A1RET
SCHEMBL8910687 0.72 FFAR1 (0.56) GRM5FFAR1ALDH1A1CYP1A2TP53
SCHEMBL13864873 0.72 GRM5 (0.46) GRM5FFAR1TDP1ALDH1A1RET
SCHEMBL7333612 0.71 ALDH1A1 (0.42) GRM5FFAR1TDP1ALDH1A1CYP1A2
SCHEMBL1314814 0.71 TDP1 (0.42) GRM5FFAR1TDP1ALDH1A1CYP1A2
SCHEMBL101714 0.71 TSHR (0.52) GRM5FFAR1TDP1ALDH1A1CYP1A2
SCHEMBL30509593 0.71 TSHR (0.52) GRM5FFAR1TDP1ALDH1A1CYP1A2
SCHEMBL1610597 0.71 TDP1 (0.42) GRM5FFAR1TDP1ALDH1A1CYP1A2
SCHEMBL1611249 0.71 TDP1 (0.42) GRM5FFAR1TDP1ALDH1A1CYP1A2
SCHEMBL3220960 0.71 TDP1 (0.42) GRM5FFAR1TDP1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9163046-B2 Process for producing substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2015-10-20 US disclosed
US-20100113717-A1 Process For Producing Substituted Metallocene Compounds For Olefin Polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2010-05-06 US disclosed
US-7709670-B2 Process for producing substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-05-04 US disclosed
EP-1866322-B1 PROCESS FOR PRODUCING SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2010-02-24 EP disclosed
EP-1866322-A2 PROCESS FOR PRODUCING SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION ExxonMobil Chemical Patents Inc. (US) 2007-12-19 EP disclosed
US-20060160968-A1 Process for producing substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-07-20 US disclosed
WO-2006065844-A2 PROCESS FOR PRODUCING SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113717-A1 Process For Producing Substituted Metallocene Compounds For Olefin Polymerization OSBP, OSBPL3, OSBP2 GRM5 1924/4885FFAR1 4213/4885TDP1 3995/4885
US-20060160968-A1 Process for producing substituted metallocene compounds for olefin polymerization OSBP, OSBPL3, OSBP2 GRM5 1924/4885FFAR1 4213/4885TDP1 3995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.